HemaCare Corporation, a Charles River Company
Biotechnology ResearchCalifornia, United States51-200 Employees
HemaCare, a Charles River company, provides human-derived biological materials and related services for biomedical research, drug discovery, and cellular therapy process development. It operates a network of collection centers with access to an extensive recallable and reliable donor network, supplying fresh and cryopreserved starting material as well as isolated cellular material derived from peripheral blood, bone marrow, and cord blood. These materials support the development of next-generation cell and gene therapies and are integrated with Charles River’s discovery, safety assessment, and manufacturing capabilities to cover stages from early research to commercialization. Based in Northridge, California, the company sits in the biotechnology research industry and serves researchers and developers seeking high-quality, customizable human cellular materials and related services. It became part of Charles River around 2020. A notable recent development is the launch of the GMPrime cryopreserved leukopak in 2020, expanding its product portfolio.